Parasitoid venom opens new fronts in biocontrol

Proteins from parasitoid insect venom have moved beyond a role solely focused on immunosuppression. Research describes these compounds as systems for manipulating the host's physiological processes. They act on melanization, the prophenoloxidase cascade, cellular and humoral immunity, development, metabolism, and behavior. The experimental basis largely comes from members of the order Hymenoptera. Outside of this group, the parasitoid beetle Dastarcus helophoroides emerges as one of the most promising comparative models.

The study compiled data on the identification, function, evolution, and potential use of these proteins in biological control. The researchers highlight a shift in concept. The venom not only protects eggs and larvae against encapsulation, melanization, hemocytes, and antimicrobial peptides, but it also prepares the host as a resource for parasitoid development.

Six lines of action

Scientists identify six main axes of action. The proteins can block melanization and the prophenoloxidase cascade. They can also disrupt cellular immunity, suppress humoral responses, interrupt development, redirect metabolic flows, and alter neuromuscular or behavioral functions. This set supports the interpretation of the venom as a multifunctional system of effectors.

Molecular knowledge remains focused on parasitoid wasps. Systems such as Nasonia vitripennis, Pteromalus puparum, Microplitis mediator, Habrobracon hebetor, Pachycrepoideus vindemmiae, Sclerodermus guani, Leptopilina spp. and Cotesia spp. provide most of the mechanistic evidence. In many cases, individual proteins have already had their function validated by recombinant assays, RNA interference, transgenic expression, or biochemical analyses.

Examples of uses

In Pteromalus puparum, for example, the venom reduces the expression of cecropine and lysozyme in Pieris rapae. A single injection suppresses 113 transcripts in hemocytes and 221 transcripts in the fat body in one hour. In Habrobracon hebetor, the venom halves capsule melanization, decreases phenoloxidase activity to one-third of the controls on the second day, and reduces hemocyte scattering capacity from sixty-seven percent to thirty-three percent in one hour.

The case of Dastarcus helophoroides expands the discussion to Coleoptera. The larva acts as an ectoparasitoid of cerambycids, among them Monochamus alternatus. Following parasitism, melanization of the host's hemolymph is inhibited in the early stages. Phenoloxidase activity exhibits a biphasic dynamic, with transient stimulation at four hours, inhibition at twelve hours, and subsequent return to baseline levels. Antibacterial activity decreases within the first hour. Total hemocyte abundance falls below half that of controls at seventy-two hours.

Molecular level

At the molecular level, scientists have recorded fifty candidate proteins that are venom-like factors in newborn larvae of Dastarcus helophoroides. The set includes nineteen arginine kinases, ten chitinases, and twenty-one proteases or protease inhibitors. The salivary gland emerges as a possible source or storage site, since the larva paralyzes and feeds on the host through its mouthparts, not by ovipositor. This hypothesis still lacks anatomical confirmation.

The predominance of arginine kinases is noteworthy. Seventeen of the nineteen proteins in this group appear in greater abundance in neonate larvae than in late-stage larvae. Researchers associate this difference with the possibility of their involvement in the initial paralysis of the host; however, they remain cautious. Because the study used whole-body proteomics, some of the candidates may represent abundant proteins without secretory function.

Chitinases also open up a hypothesis linked to an ectoparasitoid lifestyle. They may participate in cuticle degradation or modification of the feeding site. This mechanism would be consistent with the larva's external feeding through the host's integument. Confirmation requires identification of the secretory tissue, gland-resolved transcriptome, recombinant assays, and RNA interference on priority candidates.

Practical application

Practical application still depends on intermediate steps. Scientists indicate greater viability in the use of venom proteins as synergists in integrated pest management, rather than as isolated broad-spectrum biopesticides. The most sustained uses involve increasing the susceptibility of pests to microbial agents, altering host development, and interfering with competition between parasitoids in mass rearing or augmentative release programs.

Dastarcus helophoroides already has an operational history in forest management in China. Mass releases have achieved up to 91.48 percent corrected control of Monochamus alternatus in felled trees. Other studies have reported corrected population reductions between eighty-two and eighty-six percent, with adjustment for the proportion and timing of release. In Massicus raddei, releases with egg cartons resulted in a corrected reduction of eighty-eight point six percent.

Four central points

Translating these findings into molecular products or tools faces four key challenges. The first involves delivery. Many venom proteins need to reach the hemocoel or hemocytes and do not function like classic oral toxins. The second involves specificity and safety for non-target organisms. The third involves the evolution of resistance. The fourth involves positioning within integrated pest management.

The researchers also point to scientific bottlenecks. Different collection methods generate different proteomic profiles. Reservoir content, whole-body extracts, artificial host collection, and whole-body larval extracts do not produce equivalent results. In the case of Dastarcus helophoroides, whole-body proteomics has allowed progress in the face of the small size of the larvae, but it does not replace anatomical sampling of secretory tissue.

The genome of Dastarcus helophoroides already provides support for the next step. The chromosome-level assembly has 609 megabases, 14,890 predicted coding genes, and 13 chromosomes. Thus, the main bottleneck no longer involves only genomic resources. It now involves locating the secretory tissue, generating a transcriptome of that tissue, and experimentally validating individual effectors.

Further information at doi.org/10.3390/insects17060608